StonvexLoading…
StonvexStonvexStonvexCore line items from ACOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.53M | $10.22M | $7.43M | $4.59M |
Operating Income | $-8.10M | $-22.66M | $-14.74M | $-9.42M |
Net Income | $-6.48M | $-20.67M | $-13.81M | $-12.50M |
EPS (Diluted) | $-0.32 | $-1.18 | $-0.87 | $-0.78 |
Total Assets | $69.25M | $79.73M | $46.30M | $45.12M |
Total Liabilities | $11.79M | $17.20M | $12.39M | $13.23M |
Cash & Equivalents | $54.25M | $66.05M | $35.40M | $39.41M |
Free Cash Flow OCF − CapEx | $-11.80M | $-20.67M | $-13.62M | $-8.26M |
Shares Outstanding | 21.77M | 21.74M | 16.25M | 16.02M |